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ChIP-seqCTCF is a key regulator of nuclear chromatin structure, chromatin organization and gene regulation. The impact of
CTCF on transcriptional output is quite varied, ranging from repression, to transcriptional pausing and
transactivation. The multifunctional nature of CTCF is mediated, in part, through differential association with
protein partners having unique properties. We identiﬁed the general transcription factor TFII-I as an interacting
partner of CTCF. To gain an understanding of the function of TFII-I in regulating gene expression and CTCF binding
genome wide, we conducted microarray experiments following TFII-I knockdown and chromatin immunopre-
cipitation of CTCF followed by next generation sequencing (ChIP-seq) from the same TFII-I depleted cells.
Here, we described the experimental design and the quality control and analysis that were performed on the
dataset. The data is publicly available through the GEO database with accession number GSE60918. The interpre-
tation and description of these data are included in a manuscript in revision (1).
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).SpeciﬁcationsOrganism/cell
line/tissueMus Musculus, Wehi-231, B lymphocyte immatureStrain (BLAB/c x NZB) F1
Sequencer or
array typeIllumina HiSeq 2000 and Illumina BeadChips Mouse WG-6Data format ChIP-seq: Raw (Fastq) and processed (bed ﬁle and bedgraph ﬁle)
Microarray: excel spreadsheet before and after normalization.Experimental
factorsWehi231-CT vs Wehi231-TFII-I knockdownExperimental
featuresMicroarray gene expression proﬁling to identify genes that
are regulated by TFII-I.
ChIP-seq purpose was to map CTCF binding sites affected by
TFII-I depletion.Consent NA
Sample source
locationNADirect link to deposited data
Deposited data are available here: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE60918.r).
. This is an open access article underExperimental design, materials and methods
Cell line
Themouse B lymphocyte cell linesWehi-231 expressing shRNA con-
struct Control (Wehi-CT) or a shRNA construct directed against the
transcription factor TFII-I (Wehi-TKII-I-KD) were used to investigate
the effect of TFII-I depletion on global gene expression and CTCF
binding.
Microarray and quality control
To identify genes regulated by TFII-I, we extracted total RNA from
Wehi-CT and Wehi-TFII-I-KD from three independent samples. The
quantity and the quality of the RNA samples were assessed by a
Nanodrop spectrophotometer and Agilent Bioanalyser. Illumina
BeadChIPs MouseWG-6 was used to perform expression analysis. Data
preprocessing was carried out with Bioconductor package “lumi”, and
we used log2 transformation followed by quantile normalization [2,3].
Quality controls were performed before (Fig. 1A) and after (Fig. 1B) mi-
croarray data preprocessing. Reproducibility between biological repli-
cates was evaluated by calculating the correlation coefﬁcient R2 (see
example of the scatter plot Fig. 1C and D). Clustering of the microarray
was performed to ensure correct segregation between Control and
TFII-I knockdown samples (Fig. 1E). Identiﬁcation of differentially
expressed genes between Wehi-CT and Wehi-TFII-I-KD was madethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Effect of normalization onmicroarray signal intensity. Before (A) and after (B) normalization distribution of signal intensity by array. (C) and (D) are scatter plots showing the com-
parison between two biological replicates of the log2 expression value. R2= 0.95 and R2= 0.94. (E) Cluster dendogram of the arrays in function of change in gene expression. (F) Volcano
plots contrast signiﬁcance as the negative logarithm of the p-value against log fold change between control cells and TFII-I knockdown cells.
Table 1
List of genes differentially regulated.
List of differentially expressed genes (p b 0.05) with a fold change N2 identiﬁed by microarray
Up-regulated genes (55) Down-regulated genes (62)
ALDH3B1 WDR6 ATP6AP2 STARD13 GTF2I ZFP219 MIB1 LIAS
CNR2 LMCD1 SFRS11 RAB8B EGFL7 CYTIP ZBTB17 RILPL2
CNR2 LSM14A DEK POLR3G CYTH4 TBC1D10C SHC1 STC2
LMCD1 ZFYVE26 MSH6 AATF SLMO2 GSTT1 PFN1 FTL1
LRRC33 ANKRD49 HPRT1 NPM3 IL12A NANS D10ERTD610E 2310033F14RIK
BLK AGPS PLSCR1 POLE3 3300001G02RIK 2310008H09RIK 1600002K03RIK GSTO1
AURKA AF067061 RNF145 FAM178A KHK 6330442E10RIK TRUB2 1810026J23RIK
DDX24 TCIRG1 HAAO VEGFB CLEC2D EBPL ACTB BST2
CREG1 BLVRB GNAS YBX3 1600012P17RIK EIF2S2 RPN2 LOC629364
POLR2A RBBP7 VPREB3 C730026J16 CALM3 PICK1 TMEM11 GUSB
ARPP19 MLLT4 CHFR PLEKHA2 SERPINF1 MARCKS HIST1H2BJ AP3D1
PREI4 PANK4 GPR107 UBE2G1 PSMD8 CBR3 SEC63 RBM47
CEP120 DCPS MT1 CKM CDR2 SYNCRIP VARS LOC100044172
TWSG1 PDZD11 CDC5L LCE1M FCRL5 GPHN DYNC1LI1
KEAP1 JAGN1 FCGR2B RRM2
WDR68 EHD1
Table 2
Reads count and numbers of peaks.
Number of reads in millions
Sample names Antibody Cell lines Raw No duplicate MAPQ ≥ 20 Peak number
Ctl1 CTCF Wehi-CT 43.58 36.1 28.6 24467
Ctl2 CTCF Wehi-CT 36.1 32.9 26.1 23873
KD1 CTCF Wehi-TFII-I-KD 36.2 32.3 25 19076
KD2 CTCF Wehi-TFII-I-KD 36.46 23.7 16.9 15309
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Fig. 2.Quality control for ChIP-seq raw data and alignment ﬁle. (A) Graph representing the per base quality using the Phred score. Pie chart obtainedwith SAMstat describing the distribution of the sequence alignment quality score before (B) or after
(C) ﬁltering. (D) Peak model produce by MACS. (E) Venn diagram representing the overlap of CTCF binding sites between biological replicates.
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Fig. 3.Visualization of CTCF ChIP-seq data in the UCSC genome browser. Screenshot of UCSC genome browser showing CTCF ChIP-seq results in the Control and TFII-I knockdown samples.
Previously published dataset for CTCF ChIP-seq in another hematopoietic cell line is also shown.
20 M. Marques et al. / Genomics Data 4 (2015) 17–21using Bioconductor package “limma” as shown with a volcano plot in
Fig. 1F [4]. We identiﬁed 117 genes differentially regulated with a fold
chance ≥2 and p-value ≤ 0.05 listed in Table 1. As a conﬁrmation of
the knockdown efﬁciency, we found Gtf2i, the gene coding for TFII-I,
being the gene the most down regulated in our data.ChIP-seq
To identify the CTCF binding sites that were affected by TFII-I deple-
tion, we carried two independent ChIP-seq assays CTCF inWehi-CT and
Wehi-TFII-I-KD cells with CTCF antibody. Brieﬂy, cells were collected
and crosslinked with 1% folmaldehyde in PBS for 10 min at room tem-
perature. Crosslinking reaction was stooped with Glycerine 125 mM
and cells were washed with PBS and stored at−80 °C until assay was
carried out. Cells were lysed and DNA sheered by sonication with cell
lysis/ChIP buffer (0.25% NP-40, 0.25% Trinton-X, 0.25% Sodium
deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, 50 mM NaCl, 5 mM EDTA)
for 15 s, 15 times. Lysed cells were centrifuged for 15 min at
14,000 rpm at 4 °C and supernantant was collected. 1 mg of protein
was precleared for 2 hwith Protein G agarose beads (50% slurry blocked
with salmon sperm) at 4 °C. Immunoprecipitation was carried out
by adding 2 μg of antibody and 30 μl of agarose G beads and nutated
overnight at 4 °C. After immunoprecipitation, beads were pelleted by
centrifugation and were washed 4 times to remove unspeciﬁc binding
using buffers with varying concentrations of salt. Buffers 1 to 3
contained 0.1% SDS, 1% Triton-X, 2 mM EDTA, 20 mM Tris pH 8.0 and
150 mM NaCl, 300 mM Nacl, 500 mM NaCl respectively. Buffer 4
contained 0.25 M LiCl, 1% NP-40, 1% Sodium deoxycholate, 1 mM
EDTA and 10 mM Tris pH8.0. Two additional washes with TE were
done to remove any residual buffer from the beads. Complexes bound
to the beads were eluted with 500 μl of elution buffer (1% SDS, 1 mM
EDTA, 50mMTris pH 8.0) at 65 °C for 25minwith occasional vortexing.
Beads were pelleted by centrifugation and supernatant was collected.
Crosslink reversal was achieved by adding 0.2mMNaCl at 65 °C over-
night. Next proteins (including DNA bound factors and antibodies)
were degraded by a treatment with Proteinase K, carried at 45 °C for
1 h and a second incubation of 15 min at 65 °C. PCR puriﬁcation kit
(Qiagen)was used to retrieve the DNA followingmanufactured instruc-
tion and store at −20 °C. DNA was sent to the IRIC (Institut de
Recherche en Immunologie et Cancérologie, Montreal, Canada) se-
quencing facility where both the library construction and sequencing
(100bases, paired-end, HiSeq2000, Illumina) were carried out (Table 2).ChIP-seq quality control and analysis
Quality of the sequencing was assessed using FastQC software, an
example is presented in Fig. 2A (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). Using FastX tool kit (http://
hannonlab.cshl.edu/fastx_toolkit/), DNA sequences obtained were
trimmed to 45 bases, ﬁltered for high quality scores (N30), and dupli-
cates were removed before being aligned to the mouse genome (U.S.
National Center for Biotechnology Information (NCBI) Build 37, July
2007, mm9) using the BWA algorithm [5]. Quality of the alignment
was assessed using SAMStat and only the sequences with MAPQ score
≥30 were kept for further analysis (Fig. 2B and C) [6]. The model
based analysis of ChIP-Seq peak-ﬁnding algorithmwas used to identify
peaks in Wehi-CT and Wehi-TFII-I-KD conditions using the default set-
tings and an example of peak model obtain with MACS is presented in
Fig. 2D [7]. Overlap for CTCF binding sites between biological replicates
was assessed using the intersect function of bedtools [8], the results are
shownwith Venn diagram (Fig. 2E). HOMERwas used to annotate CTCF
peaks, determine their genomic distribution and generated the
bedgraph ﬁles to visualize the results in UCSC Genome Browser
(homer.salk.edu/). We used previously published CTCF ChIP-seq data
available in the UCSC genome browser as controls for our dataset
(Fig. 3).Discussion
Here, we described a dataset containing gene expression proﬁling
using Illumina BeadChips (microarray) and ChIP-seq analysis of CTCF
binding in mouse B cell lymphocyte cell lines expressing a shRNA con-
struct against TFII-I, a general transcription factor. These data were gen-
erated to analyze the inﬂuence of TFII-I on the genomic targeting of the
epigenetic regulatory protein CTCF, and understand how these two fac-
tors co-regulate gene transcription. With this dataset, we were able to
show that TFII-I is important for targeting CTCF to a cohort of promoter
regions where they co-operate to activate transcription. This ﬁnding
sheds new light on how CTCF targeting at speciﬁc genomic regions
can occur.Conﬂict of interest
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